ClinicalTrials.gg
CompletedNCT04235452Updated Jan 22, 2020

Electrophysiological Characteristics and Anatomical Differentiation of Epileptic and Non-epileptic Myoclonus.

An observational study in Myoclonus and Evoked Potential, sponsored by Mansoura University Hospital. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2020-01-22.

Sponsored by Mansoura University Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
50
Sex
All
01

Study summary

This study was conducted on a series of patients with myoclonus to identify the electrophysiological characteristics and the anatomical classification of myoclonus of different causes.

Read the detailed description

The current study included 50 patients with different types of myoclonus in comparison to 30 control subjects. Electrophysiological study was done for all patients by Somatosensory Evoked Potential (SSEP) and Electroencephalography (EEG) while the control group underwent SSEP. SSEP was studied in the patients and control group by stimulation of right and left median nerves.

02

Conditions studied

  • Myoclonus
  • Evoked Potential

Browse trials for

Keywords

  • Myoclonus, Evoked potential
03

In context

Myoclonus

20 studies on the registry are indexed under Myoclonus; 6 are open to participants now.

Browse Myoclonus studies →

Lead sponsor

Mansoura University Hospital is the lead sponsor of 50 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

50 patients with myoclonus of different etiologies (primary and secondary myoclonus).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Myoclonus classified into primary and secondary myoclonus.

Exclusion criteria

Exclusion Criteria:

  • Psychiatric comorbidity to exclude psychological myoclonus.
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
50 participants (actual)
Patient registry
No

Groups and cohorts

  • Epileptic myoclonus

    Juvenile Myoclonic Epilepsy and Progressive Myoclonic Epilepsy

    Diagnostic Test: Somatosensory evoked potential

  • Non-epileptic myoclonus (secondary)

    Post hypoxic myoclonus, Post ischemic stroke myoclonus, Hepatic, Chronic kidney disease, and Drug induced myoclonus

    Diagnostic Test: Somatosensory evoked potential

Interventions

  • Diagnostic testSomatosensory evoked potential

    Stimulation of the right and left median nerves for each subject were carried out with electrical square wave pulses of 0.2 ms duration applied at a rate of 5 HZ. with cathode proximally. The intensity of the stimulus was adjusted to produce minimal twitches of the thumb (1-2 cm thumb movement). Five hundred (500) stimuli were delivered. The recording electrode picked up the responses. They were then summated and averaged. The final evoked potential was then displayed on the screen. When two reproducible SEPs responses were obtained the data was accepted for analysis. The graph was printed out on paper, for the purpose of simplification only one response was printed out.

06

What researchers measure

Primary outcomes

  1. Somatosensory evoked potential

    Stimulation of the right and left median nerves for each subject were carried out with electrical square wave pulses of 0.2 ms duration applied at a rate of 5 HZ. with cathode proximally. The intensity of the stimulus was adjusted to produce minimal twitches of the thumb (1-2 cm thumb movement). Five hundred (500) stimuli were delivered. The recording electrode picked up the responses. They were then summated and averaged. The final evoked potential was then displayed on the screen. When two reproducible SEPs responses were obtained the data was accepted for analysis. The graph was printed out on paper, for the purpose of simplification only one response was printed out.

    Time frame: 24-72 hours

07

Study locations

1 site
  • Mansoura University Hospital
    Mansoura, Dakahlia 35516, Egypt
08

References and documents

Publications

  • Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol. 2010 Jan;6(1):29-37. doi: 10.1038/nrneurol.2009.196. PubMed 20057497 ↗
  • Agarwal P, Frucht SJ. Myoclonus. Curr Opin Neurol. 2003 Aug;16(4):515-21. doi: 10.1097/01.wco.0000084231.82329.9c. PubMed 12869812 ↗
  • Alvarez, V. & Rossetti, A. O. 2015. Electroencephalography and Evoked Potentials: Technical Background. Clinical Neurophysiology in Disorders of Consciousness. Springer. 7-23.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04235452
Lead sponsor
Mansoura University Hospital
Responsible party
Ahmed Esmael (Assistant Prof of Neurology, Mansoura University Hospital) — Principal investigator
First posted
Jan 22, 2020
Start date
Nov 1, 2018
Primary completion
Aug 31, 2019
Completion
Oct 31, 2019
Last update
Jan 22, 2020

Study contacts

Esmael Ahmed, MD
principal investigator · Assistant Prof of Neurology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion